186 related articles for article (PubMed ID: 1742726)
1. Differential expression of bcl2 protooncogene in neuroblastoma and other human tumor cell lines of neural origin.
Reed JC; Meister L; Tanaka S; Cuddy M; Yum S; Geyer C; Pleasure D
Cancer Res; 1991 Dec; 51(24):6529-38. PubMed ID: 1742726
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of the Bcl-2 oncoprotein in human neuroblastomas. Comparisons with tumor cell differentiation and N-Myc protein.
Krajewski S; Chatten J; Hanada M; Reed JC
Lab Invest; 1995 Jan; 72(1):42-54. PubMed ID: 7837790
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
[TBL] [Abstract][Full Text] [Related]
4. Expression of the smg p25A (a ras p21-like GTP-binding protein) gene in human neuroblastoma cell lines and tumor tissues.
Sano K; Nakamura H; Mabuchi S; Tanaka T; Nakagawara A; Takai Y
Cancer Res; 1990 Nov; 50(22):7242-5. PubMed ID: 2121331
[TBL] [Abstract][Full Text] [Related]
5. Neuroblastoma: inverse relationship between expression of N-myc and NGF-r.
Christiansen H; Christiansen NM; Wagner F; Altmannsberger M; Lampert F
Oncogene; 1990 Mar; 5(3):437-40. PubMed ID: 2156211
[TBL] [Abstract][Full Text] [Related]
6. The expression of multiple proto-oncogenes is differentially regulated during retinoic acid induced maturation of human neuroblastoma cell lines.
Thiele CJ; Deutsch LA; Israel MA
Oncogene; 1988 Sep; 3(3):281-8. PubMed ID: 3060792
[TBL] [Abstract][Full Text] [Related]
7. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
[TBL] [Abstract][Full Text] [Related]
8. Multiple defects of the nerve growth factor receptor in human neuroblastomas.
Azar CG; Scavarda NJ; Reynolds CP; Brodeur GM
Cell Growth Differ; 1990 Sep; 1(9):421-8. PubMed ID: 1963076
[TBL] [Abstract][Full Text] [Related]
9. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
[TBL] [Abstract][Full Text] [Related]
10. HMGI(Y) and HMGI-C genes are expressed in neuroblastoma cell lines and tumors and affect retinoic acid responsiveness.
Giannini G; Di Marcotullio L; Ristori E; Zani M; Crescenzi M; Scarpa S; Piaggio G; Vacca A; Peverali FA; Diana F; Screpanti I; Frati L; Gulino A
Cancer Res; 1999 May; 59(10):2484-92. PubMed ID: 10344762
[TBL] [Abstract][Full Text] [Related]
11. Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells.
Kim MS; Kim CJ; Jung HS; Seo MR; Juhnn YS; Shin HY; Ahn HS; Thiele CJ; Chi JG
J Pathol; 2004 Jan; 202(1):103-12. PubMed ID: 14694527
[TBL] [Abstract][Full Text] [Related]
12. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.
Reed JC; Stein C; Subasinghe C; Haldar S; Croce CM; Yum S; Cohen J
Cancer Res; 1990 Oct; 50(20):6565-70. PubMed ID: 2208117
[TBL] [Abstract][Full Text] [Related]
13. Cell cycle analysis of p26-BCL-2 protein levels in proliferating lymphoma and leukemia cell lines.
Reed JC; Tanaka S; Cuddy M
Cancer Res; 1992 May; 52(10):2802-5. PubMed ID: 1581893
[TBL] [Abstract][Full Text] [Related]
14. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
[TBL] [Abstract][Full Text] [Related]
15. Nerve growth factor-induced differentiation of human neuroblastoma and neuroepithelioma cell lines.
Chen J; Chattopadhyay B; Venkatakrishnan G; Ross AH
Cell Growth Differ; 1990 Feb; 1(2):79-85. PubMed ID: 1964795
[TBL] [Abstract][Full Text] [Related]
16. High-level expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas.
Eggert A; Ikegaki N; Kwiatkowski J; Zhao H; Brodeur GM; Himelstein BP
Clin Cancer Res; 2000 May; 6(5):1900-8. PubMed ID: 10815914
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of N-myc in phenotypically distinct subclones of a human neuroblastoma cell line.
Foley J; Cohn SL; Salwen HR; Chagnovich D; Cowan J; Mason KL; Parysek LM
Cancer Res; 1991 Dec; 51(23 Pt 1):6338-45. PubMed ID: 1933896
[TBL] [Abstract][Full Text] [Related]
18. Lack of correlation between N-myc and MAX expression in neuroblastoma tumors and in cell lines: implication for N-myc-MAX complex formation.
Raschella G; Romeo A; Negroni A; Pucci S; Dominici C; Castello MA; Bevilacqua P; Felsani A; Calabretta B
Cancer Res; 1994 Apr; 54(8):2251-5. PubMed ID: 8174135
[TBL] [Abstract][Full Text] [Related]
19. In vitro modulation and relationship between N-myc and HLA class I RNA steady-state levels in human neuroblastoma cells.
Gross N; Beck D; Favre S
Cancer Res; 1990 Dec; 50(23):7532-6. PubMed ID: 1701347
[TBL] [Abstract][Full Text] [Related]
20. Human neuroblastoma cells express alpha and beta platelet-derived growth factor receptors coupling with neurotrophic and chemotactic signaling.
Matsui T; Sano K; Tsukamoto T; Ito M; Takaishi T; Nakata H; Nakamura H; Chihara K
J Clin Invest; 1993 Sep; 92(3):1153-60. PubMed ID: 8376577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
